A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA

NCT01709760 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: ENIA11
DRUG: Placebo

Sponsor

Mycenax Biotech Inc.